Surgery for infective endocarditis following low-intermediate risk transcatheter aortic valve replacement-a multicentre experience.
Shekhar SahaDominik JoskowiakMateo Marin-CuartasMahmoud DiabBenedikt M SchwaigerRodrigo Sandoval-BoburgAron Frederik PopovCarolyn WeberSam VargheseAndreas MartensSerghei CebotariMaximilian SchernerWalter EichingerDavid HolzheyDaniel-Sebastian DohleThorsten WahlersTorsten DoenstMartin MisfeldJulinda MehilliSteffen MassbergChristian HaglPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
Our results suggest that TIE can be treated according to the guidelines for prosthetic valve endocarditis, namely with early surgery. Surgery for TIE is associated with acceptable morbidity and mortality rates. Surgery should be discussed liberally as a treatment option in patients with TIE by the 'endocarditis team' in referral centres.
Keyphrases
- minimally invasive
- coronary artery bypass
- transcatheter aortic valve replacement
- aortic valve
- surgical site infection
- aortic stenosis
- clinical trial
- primary care
- palliative care
- randomized controlled trial
- percutaneous coronary intervention
- mitral valve
- heart failure
- coronary artery disease
- left ventricular
- study protocol
- combination therapy
- replacement therapy
- newly diagnosed